Article thumbnail

CMR in Heart Failure

By Daniel M. Sado, Jonathan M. Hasleton, Anna S. Herrey and James C. Moon


Heart Failure (HF) is a common syndrome with multiple causes. Cardiovascular magnetic resonance (CMR) is a medical imaging technique with significant advantages, allowing the understanding of aetiology and pathophysiology of HF in the individual patient, permitting specific therapy to be administered and predicting prognosis. This paper discusses the diverse role of CMR in HF

Topics: Review Article
Publisher: SAGE-Hindawi Access to Research
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2011). A .N .M a t h e r ,T .A .F a i r b a i r n
  2. (2004). a i s c h ,P .M .S e f e r o v i ´
  3. (2010). a r o s e ,J .R o d ´
  4. (2009). a s s o ,D .C o r r a d o ,F .I .M a r c u s ,A .N a v a ,a n dG . Thiene, “Arrhythmogenic right ventricular cardiomyopathy,”
  5. (2009). A.S.Kanderian,R.Renapurkar,andS.D.Flamm,“Myocardial viability and revascularization,”
  6. (2005). Accurate quantitation of regurgitant volume with MRI in patients selected for mitral valve repair,”
  7. (2001). Advances in the understanding of myocarditis,”
  8. (2005). Amyloid in the cardiovascular system: a review,”
  9. (2010). Assessment of atrial septal defects in adults comparing cardiovascular magnetic resonance with transoesophageal echocardiography,”
  10. (2002). Assessment of myocardial viability by cardiovascular magnetic resonance imaging,”
  11. (2010). Assessment of severe reperfusion injury with T2∗ cardiacMRIinpatientswithacutemyocardialinfarction,”
  12. (2011). Beat-to-beat respiratory motion correction with near 100% efficiency: a quantitative assessment using high-resolution coronary artery imaging,”
  13. (2008). Cardiac imaging: MR or CT? Which to use when,”
  14. (2008). Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach,”
  15. (2008). Cardiovascular magnetic resonance imaging detects cardiac involvement in churg-strauss syndrome,”
  16. (2005). Cardiovascular magnetic resonance in cardiac amyloidosis,”
  17. (2009). Cardiovascular magnetic resonance in myocarditis: a JACC white paper,”
  18. (2006). Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy,”
  19. (2001). Cardiovascular T2-star (T2∗) magnetic resonance for the early diagnosis of myocardialironoverload,”EuropeanHeartJournal,vol.22,no. 23,
  20. (2010). Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging,”
  21. (2010). CMR for characterization of the myocardium in acute coronary syndromes,”
  22. (2003). Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction,”
  23. (2004). Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with nondiagnostic echocardiography,”
  24. (2010). Development and validation of risk adjustment models for long-term mortality and myocardial infarction following percutaneous coronary interventions,”
  25. (2010). Diagnosis of arrhythmogenic right ventricular cardiomyopathy/Dysplasia: proposed modification of the task force criteria,”
  26. (2011). Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest painCardiology Research and Practice 11 syndrome and unobstructed coronary arteries,”
  27. (2009). Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study,”
  28. (2003). Effect of left ventricular outflow tract obstruction on clinical outcome
  29. (2010). ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): the task force on the management of grown-up congenital heart disease of the
  30. (2011). Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance,”
  31. (1999). From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future,” Circulation,
  32. (2003). Gadolinium enhanced cardiovascular magnetic resonance in AndersonFabry disease: evidence for a disease specific abnormality of the myocardial interstitium,”
  33. (2006). guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on
  34. (1999). Guidelines for the study of familial dilated cardiomyopathies,”
  35. (2007). Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European society of cardiology,”
  36. (2009). Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction,”
  37. (1990). Isolated noncompaction of left ventricular myocardium. A study of eight cases,”
  38. (2010). l o y d - J o n e s ,R .J .A d a m s ,T .M .B r o w ne ta l . ,“ E x e c u t i v e summary: heart disease and stroke statistics-2010 update: a report from the american heart association,”
  39. (1995). l v a r e z - S a l a ,C .P r a d o s ,E .A r m a d a ,A .D e lA r c o ,a n d
  40. (2006). Long-term safety of cardiac magnetic resonance imaging performed in the first few days after bare-metal stent implantation,”
  41. (1991). Magnetic resonance imaging of great vessel, myocardial, and pericardial disease,”
  42. (2010). Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction,”
  43. (2010). Microvascular obstruction. Underlying pathophysiology and clinical diagnosis,”
  44. (2009). Nephrogenic systemic fibrosis: clinical spectrum of disease,”
  45. (2009). O.Bruder,S.Schneider,D.Nothnageletal.,“EuroCMR(European Cardiovascular Magnetic Resonance) registry. Results of the german pilot phase,”
  46. (2003). Practical value of cardiacmagneticresonanceimagingforclinicalquantification of aortic valve stenosis: comparison with echocardiography,”
  47. (2010). Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy,”
  48. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation myocardial infarction,” Circulation.
  49. (1990). S e m e l k a ,E .T o m e i ,S .W a g n e re ta l . ,“ N o r m a ll e f tv e n -tricular dimensions and function: interstudy reproducibility of measurements with cine
  50. (2008). Standardized cardiovascular magnetic resonance imaging(CMR)protocols,societyforcardiovascularmagnetic resonance: board of trustees task force on standardized protocols,”
  51. (2000). Survival in β-thalassaemia major in the UK: data from the UK thalassaesnia register,”
  52. (1979). The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow,”
  53. (2000). The use of contrastenhanced magnetic resonance imaging to identify reversible myocardial dysfunction,” The New England
  54. (2009). The utility of cardiovascular magnetic resonance in constrictive pericardial disease,”
  55. (2009). The utility of delayed-enhancement magnetic resonance imaging for identifying nonischemic myocardial fibrosis in asymptomatic patients with biopsy-proven systemic sarcoidosis,”
  56. (2000). Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation,”
  57. (2008). Utility of myocardial fibrosis and fatty infiltrationdetectedbycardiacmagneticresonanceimagingin the diagnosis of arrhythmogenic right ventricular dysplasia-a single centre experience,” Heart Lung and Circulation,
  58. (2002). World Health Organisation, The World Health Report